William Blair Lowers Earnings Estimates for Simulations Plus

Simulations Plus, Inc. (NASDAQ:SLP - Free Report) - Investment analysts at William Blair reduced their Q2 2026 earnings estimates for shares of Simulations Plus in a note issued to investors on Friday, April 4th. William Blair analyst M. Smock now expects that the technology company will post earnings per share of $0.30 for the quarter, down from their previous forecast of $0.31. William Blair currently has a "Outperform" rating on the stock. The consensus estimate for Simulations Plus' current full-year earnings is $1.09 per share. William Blair also issued estimates for Simulations Plus' Q3 2026 earnings at $0.34 EPS and FY2026 earnings at $1.25 EPS.

Simulations Plus (NASDAQ:SLP - Get Free Report) last posted its quarterly earnings results on Thursday, April 3rd. The technology company reported $0.31 EPS for the quarter, beating analysts' consensus estimates of $0.25 by $0.06. Simulations Plus had a return on equity of 6.84% and a net margin of 10.97%. The business had revenue of $22.43 million for the quarter, compared to analysts' expectations of $21.93 million. During the same period last year, the firm earned $0.20 earnings per share. The business's quarterly revenue was up 22.5% on a year-over-year basis.

SLP has been the subject of a number of other research reports. StockNews.com upgraded shares of Simulations Plus from a "sell" rating to a "hold" rating in a research report on Friday, April 4th. KeyCorp increased their price objective on shares of Simulations Plus from $35.00 to $37.00 and gave the company an "overweight" rating in a report on Friday, January 24th. Two investment analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $49.40.

Simulations Plus Stock Up 26.8 %

SLP stock traded up $6.91 during midday trading on Monday, hitting $32.65. The company's stock had a trading volume of 1,775,486 shares, compared to its average volume of 185,325. Simulations Plus has a 12 month low of $23.01 and a 12 month high of $51.22. The company has a 50 day moving average of $28.88 and a two-hundred day moving average of $30.03. The firm has a market capitalization of $656.62 million, a price-to-earnings ratio of 81.63 and a beta of 1.13.

Hedge Funds Weigh In On Simulations Plus

Several large investors have recently modified their holdings of SLP. Conestoga Capital Advisors LLC boosted its stake in Simulations Plus by 15.0% during the fourth quarter. Conestoga Capital Advisors LLC now owns 2,226,262 shares of the technology company's stock worth $62,090,000 after buying an additional 290,414 shares during the period. State Street Corp grew its holdings in Simulations Plus by 4.7% during the 3rd quarter. State Street Corp now owns 640,303 shares of the technology company's stock valued at $20,503,000 after purchasing an additional 28,953 shares during the last quarter. Ameriprise Financial Inc. raised its position in Simulations Plus by 16.7% in the 4th quarter. Ameriprise Financial Inc. now owns 607,902 shares of the technology company's stock worth $16,954,000 after purchasing an additional 86,868 shares during the period. Janus Henderson Group PLC raised its position in Simulations Plus by 7,753.3% in the 4th quarter. Janus Henderson Group PLC now owns 542,899 shares of the technology company's stock worth $15,141,000 after purchasing an additional 535,986 shares during the period. Finally, Geode Capital Management LLC lifted its stake in Simulations Plus by 4.4% in the third quarter. Geode Capital Management LLC now owns 448,618 shares of the technology company's stock worth $14,367,000 after purchasing an additional 18,924 shares during the last quarter. Institutional investors own 78.08% of the company's stock.

Insider Buying and Selling at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the company's stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $33.91, for a total transaction of $678,200.00. Following the sale, the director now directly owns 3,402,584 shares in the company, valued at $115,381,623.44. This represents a 0.58 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. 19.40% of the stock is owned by company insiders.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.